Patent assignee · GB · COMPANY

Reneuron Limited

19Patents
10Active
19Granted
38Portfolio score

Filing activity: Mar 29, 2000 → Oct 9, 2014 · 6 expiring within 5 years

Most-cited patents

PatentTitleAreaCited byStatus
US7371576B2 CD56 positive human adult pancreatic endocrine progenitor cells Chemistry; Metallurgy 60 Expired
US6569421B2 Treatment of brain damage Human Necessities 30 Expired
US6399384B1 Conditional immortalization of cells Chemistry; Metallurgy 22 Expired
US7807459B2 EphA4-positive human adult pancreatic endocrine progenitor cells Chemistry; Metallurgy 7 Active
US6465215B1 Identification of cells for transplantation Chemistry; Metallurgy 7 Expired
US7416888B2 Cell lines Chemistry; Metallurgy 5 Expired
US8377689B2 EPHA4-positive human adult pancreatic endocrine progenitor cells Chemistry; Metallurgy 4 Active
US7048921B2 Neural transplantation using pluripotent neuroepithelial cells Chemistry; Metallurgy 4 Expired
US7419827B2 Cell lines Chemistry; Metallurgy 4 Expired
US7371374B2 Neural transplantation using pluripotent neuroepithelial cells Chemistry; Metallurgy 3 Expired
US7247298B2 Treatment of brain damage Human Necessities 3 Expired
US7666672B2 Cell lines Chemistry; Metallurgy 3 Active
US9068169B2 CD56 positive human adult pancreatic endocrine progenitor cells Chemistry; Metallurgy 2 Active
US8932577B2 Treatment of limb ischemia Chemistry; Metallurgy 1 Active
US9265795B2 Cellular compositions for use in therapy Human Necessities 1 Active
US9629879B2 Therapeutic use of neural stem cells Human Necessities 1 Active
US9745554B2 Method of improving cell proliferation of pancreatic progenitor cells in a pancreatic cell culture Chemistry; Metallurgy 0 Active
US10406182B2 Stem cell microparticles and miRNA Chemistry; Metallurgy 0 Active
US9410122B2 Treatment of limb ischemia Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.